73 articles
Thomas Carpenter, M.D., talks about the recent FDA approval (April 2018) of Crysvita® (burosumab-twza) for the treatment of X-Linked Hypophosphatemia (...
Kakkis, M.D., Ph.D., CEO and President of Ultragenyx discusses the recently FDA approved (April 2018) Crysvita® (burosumab-twza) for the treatment of X...
serves as AMAG’s chief medical officer and senior vice president of clinical development and regulatory affairs. Learn more on Health Professional Radio.
Segment Overview: Jeff Miller, General Manager of the Givosiran program at Alnylam discusses the ENVISION Alnylam Phase 3 trial of its investigational R...
Arthur Kavanaugh discusses the recent (Oct 2017) FDA approval of SIMPONI ARIA ® (golimumab) as the first and only fully-human anti-tumor necrosis facto...
Fuchs, MD, MPH, became Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital on January 1, 2017.
Michelle Miller Presenter: Tabetha Moreto Guests Bio: Dr Miller has over 20 years of experience in the bioscience industry, with focus on commercial dev...
Stern Presenter: Neal Howard Guests Bio: David Stern is the Chief Executive Officer of Symbiomix. Learn more on Health Professional Radio.
Jonathan Strober & Julie Presenter: Neal Howard Guests Bio: Dr. Learn more on Health Professional Radio.
Health Professional Radio: Dr. Stewart Washer discusses healthcare topics with host Wayne Bucklar. Learn more on Health Professional Radio.